Supplement Regulations

More Topics
Coronavirus1540x800.jpg
Claims
Senator calls COVID-19 warning letters ‘insufficient’Senator calls COVID-19 warning letters ‘insufficient’

More needs to be done in addition to issuing warning letters, one senator wrote, as targeted companies alter their promotions to comply.

byDuffy Hayes
Mar 10, 2020
|
1 Min Read
An emerging conundrum_CBD and the regulatory truth1540x800.jpg
Herbs & Botanicals
An emerging conundrum—CBD and the regulatory truthAn emerging conundrum—CBD and the regulatory truth
byJim Lassiter
Mar 10, 2020
1 Min Read
Trade groups irked with FDA following CBD report to Congress logo in a gray background |
Supplement Regulations
Trade groups irked with FDA following CBD report to CongressTrade groups irked with FDA following CBD report to Congress
byJosh Long
Mar 9, 2020
1 Min Read
Wave of warning letters 1540x800.jpg
Claims
Wave of warning letters sent targeting COVID-19Wave of warning letters sent targeting COVID-19
byDuffy Hayes
Mar 9, 2020
1 Min Read
Regulatory uncertainty continues in the expanding cannabinoid market 1540x800.jpg
Supplement Regulations
Regulatory uncertainty continues in the expanding cannabinoid marketRegulatory uncertainty continues in the expanding cannabinoid market
byDavid DiGiacomo, Shawn Stigler
Mar 6, 2020
1 Min Read
Reg101Webinar_NoText.jpg
Sponsored Content
Supplement Regulation 101: Need-to-Know Basics for Non-regulatory Staff – webinarSupplement Regulation 101: Need-to-Know Basics for Non-regulatory Staff – webinar
Mar 24, 2020
A CBD look back at 2019 and predictions for 2020 1540x800.jpg
Supplement Regulations
A CBD look back at 2019 and predictions for 2020
A CBD look back at 2019 and predictions for 2020
Mar 2, 2020
|
1 Min Read
bySuzanne Bassett
FDA head: It’s ‘fool’s game’ to tell people they can’t use CBD logo in a gray background | FDA head: It’s ‘fool’s game’ to tell people they can’t use CBD
Supplement Regulations
FDA head: It’s ‘fool’s game’ to tell people they can’t use CBD
FDA head: It’s ‘fool’s game’ to tell people they can’t use CBD
Feb 28, 2020
|
1 Min Read
byJosh Long
Mechanisms of action Claims and challenge 1540x800.jpg
Claims
Mechanisms of action: Claims and challenge
Mechanisms of action: Claims and challenge
Feb 28, 2020
|
1 Min Read
byJim Lassiter
Duffy Coronavirus Feature Image 1540x800.jpg
Supply Chain
FDA leaning on tools other than inspections in coronavirus response
FDA leaning on tools other than inspections in coronavirus response
Feb 27, 2020
|
1 Min Read
byDuffy Hayes
FDA to show CBD discretion 1540x800_0.jpg
Supplement Regulations
FDA: Can you show a little CBD discretion?
FDA: Can you show a little CBD discretion?
Feb 27, 2020
|
1 Min Read
bySteve Mister
class action litigation 2020
Litigation
CBD marketers raise class action defenses, face amended complaints
CBD marketers raise class action defenses, face amended complaints
Feb 27, 2020
|
1 Min Read
byJosh Long
Cannabinoid products and the law—in plain language 1540x800.jpg
Herbs & Botanicals
Cannabinoid products and the law—in plain language
Cannabinoid products and the law—in plain language
Feb 25, 2020
|
1 Min Read
byDarren Kaplan, David Bush
Trades back CBD bill, eye broader cannabinoid inclusion logo in a gray background | Trades back CBD bill, eye broader cannabinoid inclusion
Supplement Regulations
Trades back CBD bill, eye broader cannabinoid inclusion
Trades back CBD bill, eye broader cannabinoid inclusion
Feb 24, 2020
|
1 Min Read
byJosh Long
Natural Catalyst Duffy MacKay’s move from supplement trade org to hemp-specific advocacy 1540x800.jpg
Business Resources
Natural Catalysts: Duffy MacKay’s move from supplement trade org to hemp-specific advocacy
Natural Catalysts: Duffy MacKay’s move from supplement trade org to hemp-specific advocacy
Feb 24, 2020
|
1 Min Read
byTodd Pauli
UK identifies path to regulate CBD, US remains in limbo logo in a gray background | UK identifies path to regulate CBD, US remains in limbo
Supplement Regulations
UK identifies path to regulate CBD, US remains in limbo
UK identifies path to regulate CBD, US remains in limbo
Feb 20, 2020
|
1 Min Read
byJosh Long
GMP Compliance
Supplement Regulations
Supplement maker subject to massive recall was GMP-certified
Supplement maker subject to massive recall was GMP-certified
Feb 19, 2020
|
1 Min Read
bySteve Myers
FDA’s quest to regulate CBD.jpg
Supplement Regulations
FDA’s quest to regulate CBD
FDA’s quest to regulate CBD
Feb 19, 2020
|
1 Min Read
byJosh Long
CBD industry faces safety-related catch-22 logo in a gray background | CBD industry faces safety-related catch-22
Supplement Regulations
CBD industry faces safety-related catch-22
CBD industry faces safety-related catch-22
Feb 18, 2020
|
1 Min Read
byJosh Long
Growing CBD industry remarkable for its lack of regulation_0.jpg
Herbs & Botanicals
Missing regulations mark evolving CBD industry
Missing regulations mark evolving CBD industry
Feb 18, 2020
|
1 Min Read
byGary Callahan
Looking back at 2019 developments for hemp and CBD.jpg
Herbs & Botanicals
The status of hemp/CBD as 2020 gets underway
The status of hemp/CBD as 2020 gets underway
Feb 14, 2020
|
1 Min Read
byCharlotte Peyton
Supplement Bottle 2020.jpg
Supplement Regulations
FDA acknowledges nearly half of dietary ingredient notices
FDA acknowledges nearly half of dietary ingredient notices
Feb 13, 2020
|
1 Min Read
Accurate compositional analysis for precision and security.jpg
Labs/Testing
Composition analysis aids supplement precision, security
Composition analysis aids supplement precision, security
Feb 13, 2020
|
1 Min Read
byDel Williams
WADA prohibited list mods impact sports nutrition.jpg
Sports & Nutrition
WADA prohibited list mods impact sports nutrition
WADA prohibited list mods impact sports nutrition
Feb 12, 2020
|
1 Min Read
byOliver Catlin
Supplement certifications don’t mean regulatory compliance_0.jpg
Branding & Marketing
Product certifications not a certainty of legal compliance
Product certifications not a certainty of legal compliance
Feb 11, 2020
|
1 Min Read
byJim Lassiter
FDA wants $5 million for cannabis regulation logo in a gray background | FDA wants $5 million for cannabis regulation
Supplement Regulations
FDA wants $5 million for cannabis regulation
FDA wants $5 million for cannabis regulation
Feb 11, 2020
|
1 Min Read
byJosh Long
USDA hemp rule needs big changes, more groups say logo in a gray background | USDA hemp rule needs big changes, more groups say
Supplement Regulations
USDA hemp rule needs big changes, more groups say
USDA hemp rule needs big changes, more groups say
Feb 10, 2020
|
1 Min Read
byTodd Runestad
Promising cannabinoid alternatives to hemp CBD.jpg
Herbs & Botanicals
Why to focus on cannabinoids other than CBD
Why to focus on cannabinoids other than CBD
Feb 10, 2020
|
1 Min Read
byDaniel Sliva
NPI-DM-Hemp&CBD-0220-1200x400.jpg
Sponsored Content
Hemp/CBD: Market evolution – digital magazine
Hemp/CBD: Market evolution – digital magazine
Feb 6, 2020
|
1 Min Read
Let’s talk hemp CBD safety – podcast
Supplement Regulations
Let’s talk hemp CBD safety – podcast
Let’s talk hemp CBD safety – podcast
Feb 4, 2020
byTodd Runestad
User fees could boost FDA oversight of supplement sector logo in a gray background | User fees could boost FDA oversight of supplement sector
Supplement Regulations
User fees could boost FDA oversight of supplement sector
User fees could boost FDA oversight of supplement sector
Feb 4, 2020
|
1 Min Read
byJosh Long
Questions to ask when vetting a contract manufacturer.jpg
Manufacturing
Contract manufacturing: Using positive communication to vet a partner
Contract manufacturing: Using positive communication to vet a partner
Feb 4, 2020
|
1 Min Read
byKurt Schneider
Propelling the prebiotic market.jpg
Supplements
Advancing the prebiotics market
Advancing the prebiotics market
Feb 3, 2020
|
1 Min Read
byConnor Lovejoy
Supplement contract manufacturing recall ‘unprecedented’ logo in a gray background | Supplement contract manufacturing recall ‘unprecedented’
Supplement Regulations
Supplement contract manufacturing recall ‘unprecedented’
Supplement contract manufacturing recall ‘unprecedented’
Jan 31, 2020
|
1 Min Read
byJosh Long
5 things the USDA got wrong with its hemp proposal logo in a gray background | 5 things the USDA got wrong with its hemp proposal
Supplement Regulations
5 things the USDA got wrong with its hemp proposal
5 things the USDA got wrong with its hemp proposal
Jan 24, 2020
|
1 Min Read
byTodd Runestad
Recent headlines
Editors Choice
Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.